Phytoestrogens in application prospect of treatment of myocardial ischemia/reperfusion injury.
- Author:
Guang LI
;
Xiao-yan XING
;
Mei-shuang ZHANG
;
Jin-jin SHI
;
Xue-hong DENG
;
Gui-bo SUN
;
Xiao-bo SUN
- Publication Type:Journal Article
- MeSH:
Animals;
Humans;
Myocardial Ischemia;
drug therapy;
Myocardial Reperfusion Injury;
drug therapy;
Phytoestrogens;
administration & dosage;
Plant Extracts;
administration & dosage
- From:
China Journal of Chinese Materia Medica
2015;40(16):3132-3136
- CountryChina
- Language:Chinese
-
Abstract:
Reperfusion is the most effective treatment for acute myocardial infarction, markedly reducing mortality and morbidity. Reperfusion however induces necrotic and apoptotic damages to cardiomyocytes, that were viable prior to reperfusion, a process called myocardial ischemia/reperfusion injury(MI/RI). Over the past 30 years, hundreds of experimental interventions (both pharmacologic and nonpharmacologic) have been reported to protect the ischemic myocardium in experimental animals; however, with the exception of early reperfusion, none has been translated into clinical practice. The population-based survey assessed men have about twice the total incidence of morbidity and mortality of women, and the sex gap in morbidity tends to diminish after age 45 years. So hormone replacement therapy (HRT) is given to treat the MI/RI, and lots of studies shows that the side effect is greater for estrogen, compared with phyestrogen. In this article, we review the important pathogenesis of myocardial ischemia reperfusion injury, the prevention and limitations of HRT. And we highlight the mechanism of phyestrogens treatment the MI/RI in experiment. The aim is to provide the theoretically new way of develop the safe and effective products for the researchers.
